The University of Southampton
University of Southampton Institutional Repository

Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis

Joffres, Christine, Bucks, Romola S., Haworth, Judy, Wilcock, Gordon K. and Rockwood, Kenneth (2003) Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis Dementia and Geriatric Cognitive Disorders, 15, (1), pp. 26-33. (doi:10.1159/000066673).

Record type: Article

Abstract

The Clinician's Interview Based Impression of Change, plus carer interview (CIBIC-Plus) is widely used in anti-dementia drug trials. It includes clinicians' notes about patients' behaviour, function, and cognition, and a 7-point clinical global impression of change scale that summarizes patients' changes during treatment. We analyzed the narrative content of clinicians' notes from a randomized, controlled trial of galantamine, an anti-Alzheimer's disease drug, and identified varying degrees of improvement and decline. In general, while most patients were rated as showing 'no change', considerable changes were seen in such patients, but were judged by clinicians to have been offset by decline in other areas. Most patients rated as 'improved' showed combinations of cognitive, functional and/or behavioural improvement or stability. While patients with signs of cognitive improvement could be found across the scale from 'very much improved' to 'minimally worse', patients with functional improvement were rated as having improved or not having changed. Cognitive declines in several domains or any cognitive decline seen with functional declines were the chief drivers of worsening ratings. The CIBIC-Plus notes have potential value in identifying reproducible patterns of clinically relevant treatment effects provided that data are consistent and specific, and that seemingly contradictory information is carefully explored. Clinicians appear to be skeptical of cognitive changes not supported by like changes in function or behaviour.

Full text not available from this repository.

More information

Published date: 2003
Keywords: alzheimer's disease, cibic-plus, clinical meaningfulness, clinical trials, galantamine

Identifiers

Local EPrints ID: 18561
URI: http://eprints.soton.ac.uk/id/eprint/18561
ISSN: 1420-8008
PURE UUID: 283d9606-73b0-4a49-a1ad-8320594ccb26

Catalogue record

Date deposited: 05 Dec 2005
Last modified: 17 Jul 2017 16:35

Export record

Altmetrics

Contributors

Author: Christine Joffres
Author: Romola S. Bucks
Author: Judy Haworth
Author: Gordon K. Wilcock
Author: Kenneth Rockwood

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×